All In Biotech

Drug Trial Radar · NCT05573100

The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)

A Randomized, Open-label, Parallel-group, Multi-center Phase 2a Study to Evaluate the Efficacy and Safety of CU06-1004 for 12 Weeks in Patients With Diabetic Macular Edema (DME)

Last checked: Nov 19, 2026Latest source record: May 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

67

Actual

Start

Dec 21, 2022

Primary completion

May 31, 2023

Study completion Jun 30, 2023

Sponsor

Lead sponsor
Curacle Co., Ltd.Industry
Sponsor type
Industry
Collaborators
Théa Open Innovation, France
First posted
Oct 10, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase 2a trial is a randomized, open-label, parallel-group study in approximately 60 patients with DME to evaluate the efficacy and safety of CU06-1004 orally administered once daily for 12 weeks. The study will have a 1:1:1 randomization (CU06-1004 100mg: CU06-1004 200mg: CU06-1004 300mg).

Conditions

  • Diabetic Macular Edema

Interventions

  • CU06-1004Drug

    CU06-1004 per capsule for oral administration. CU06-1004 is a white off powder at room temperature. The CU06-1004 100 mg soft gelatin capsules consist of a solution-based fill.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The change of central subfield thickness (CST)Time frame: Baseline and 12 weeks
  2. To determine the optimal dosesTime frame: 12 weeks

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • Rand Eye Institute

    Deerfield Beach, Florida

  • Elman Retina Group

    Baltimore, Maryland

  • Cumberland Valley Retina Consultants

    Hagerstown, Maryland

  • Ophthalmic Consultants of Boston

    Boston, Massachusetts

  • New England Retina Consultants

    Springfield, Massachusetts

  • Mid Atlantic Retina

    Bethlehem, Pennsylvania

  • Austin Research Center for Retina

    Austin, Texas

  • Retina consultant of Texas

    Bellaire, Texas

  • Valley Retina Institute

    McAllen, Texas

  • Wagner Macula and Retina Center

    Norfolk, Virginia

  • Emanuelli Research & Development Center

    Arecibo, Puerto Rico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.